This study investigates the treatment for adenocarcinoma located in the pancreas region. The purpose is to evaluate a surgical approach that may help patients who are at high risk of complications after surgery.
The study focuses on assessing the effectiveness and safety of a procedure called Total Pancreatectomy with Intraportal Islet AutoTransplantation (TPIAT). It evaluates if this method can improve treatment outcomes and maintain metabolic control.
- Who can participate: Adults 18 years and older with resectable adenocarcinoma in the pancreas region may participate. Key factors include a high risk of postoperative complications and a multidisciplinary team-approved resection strategy.
- Study details: Participants will undergo a total pancreatectomy followed by islet autotransplantation. A placebo is not used in this study. This approach investigates reducing the risk of complications and improving access to further treatment.
How understandable was the trial content above?
Hard to understand
Easy to understand